TapewireFind a company

person · Reporting owner

Yarkadas Hayati

Disclosed activity across 2 companies

Tapewire entity
62240
SEC CIK
0001657363

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Trinseo PLCTSE · Entity 8671SVP & Business PresidentFebruary 26, 2019March 01, 2019
Xylem Inc.XYL · Entity 430EVP & President, WIMarch 05, 2026March 06, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Trinseo PLC

Report date February 26, 2019 · Filed March 01, 2019

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Ordinary SharesSEC Table I · non-derivativeDirect25,589 Reported balance After 2019-02-26 transaction · row 1
1 source row

Row 1 · 2019-02-26 · Grant · Acquired 3,836 · Balance 25,589

F1: Represents ordinary shares issuable pursuant to RSU award that will vest in full on the third anniversary of the grant date.

Option to Purchase Ordinary SharesSEC Table II · derivative / convertible security · Conversion / exercise price $51.02 · Expires 2028-02-26Direct52,524 Reported balance After 2019-02-26 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2019-02-26 · Grant · Acquired 12,702 · Balance 52,524

F2: The option vests in three equal annual installments beginning on the first anniversary of the grant date.

Filing footnotes · ownership attribution and instrument terms

F1: Represents ordinary shares issuable pursuant to RSU award that will vest in full on the third anniversary of the grant date.

F2: The option vests in three equal annual installments beginning on the first anniversary of the grant date.

Xylem Inc.

Report date March 05, 2026 · Filed March 06, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect33,540 Reported balance After 2026-03-05 transaction · row 1
1 source row

Row 1 · 2026-03-05 · Tax withholding · Disposed 41 · Balance 33,540

F1: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 5, 2025 (41) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

Filing footnotes · ownership attribution and instrument terms

F1: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 5, 2025 (41) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
March 01, 2022 Filed Mar 2, 2022 21:18 UTC Xylem Inc. XYL · Entity 430 SaleCommon Stock 71 $86.61 $6,149.64
Disclosure

SEC source: 0001209191-22-014719 · doc4.xml · nonDerivative · entry 1

Yarkadas Hayati · CIK 0001657363 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,298

F1 · shares: Reflects the sale of common stock to pay the tax liability incident to the vesting of restricted stock units granted on May 7, 2020 under the Xylem 2011 Omnibus Incentive Plan

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

Read SEC document
March 01, 2022 Filed Mar 3, 2022 22:03 UTC Xylem Inc. XYL · Entity 430 GrantStock Option (Right to Buy) · Derivative 15,106 $0.00 Strike: $86.76 $0.00
Disclosure

SEC source: 0001209191-22-015605 · doc4.xml · derivative · entry 3

Yarkadas Hayati · CIK 0001657363 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,106

Underlying: Common · 15,106 shares

Expires 2032-03-01

F4 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2023, March 1, 2024 and March 1, 2025.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 22:03 UTC Xylem Inc. XYL · Entity 430 GrantCommon Stock 3,458 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015605 · doc4.xml · nonDerivative · entry 2

Yarkadas Hayati · CIK 0001657363 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,713

F3 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2023, March 1, 2024 and March 1, 2025

Read SEC document
May 12, 2021 Filed May 13, 2021 20:48 UTC Xylem Inc. XYL · Entity 430 SaleCommon Stock 611 $117.10 $71,548.10
Disclosure

SEC source: 0001209191-21-032376 · doc4.xml · nonDerivative · entry 1

Yarkadas Hayati · CIK 0001657363 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,369

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 25, 2021.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

Read SEC document
May 07, 2021 Filed May 11, 2021 22:51 UTC Xylem Inc. XYL · Entity 430 SaleCommon Stock 76 $120.13 $9,129.74
Disclosure

SEC source: 0001209191-21-031851 · doc4.xml · nonDerivative · entry 1

Yarkadas Hayati · CIK 0001657363 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,980

F1 · shares: Reflects the sale of common stock to pay the tax liability incident to the vesting of restricted stock units granted on May 7, 2020 under the Xylem 2011 Omnibus Incentive Plan

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

Read SEC document
March 29, 2021 Filed Mar 30, 2021 23:21 UTC Xylem Inc. XYL · Entity 430 Disposition to issuerStock Option (Right to Buy) · Derivative 5,897 $0.00 Strike: $63.55 $0.00
Disclosure

SEC source: 0001209191-21-023626 · doc4.xml · derivative · entry 4

Yarkadas Hayati · CIK 0001657363 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,974

Underlying: Common · 5,897 shares

Expires 2030-02-27

F4 · derivative.exercise_date: On May 7, 2020 17,871 options were granted. 5,897 options vested on February 27, 2021. 5,898 options are scheduled to vest on February 27, 2022 and 6,076 options are scheduled to vest on February 27, 2023.

Read SEC document
March 29, 2021 Filed Mar 30, 2021 23:21 UTC Xylem Inc. XYL · Entity 430 SaleCommon Stock 550 $104.23 $57,324.03
Disclosure

SEC source: 0001209191-21-023626 · doc4.xml · nonDerivative · entry 3

Yarkadas Hayati · CIK 0001657363 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,056

F1 · shares: The exercise and sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 25, 2021.

F3 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 500 shares were sold at prices ranging from $103.60 and $104.53. 50 shares were sold at a price of $104.75. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

Read SEC document
March 29, 2021 Filed Mar 30, 2021 23:21 UTC Xylem Inc. XYL · Entity 430 SaleCommon Stock 5,897 $104.29 $614,971.00
Disclosure

SEC source: 0001209191-21-023626 · doc4.xml · nonDerivative · entry 2

Yarkadas Hayati · CIK 0001657363 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,606

F1 · shares: The exercise and sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 25, 2021.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

Read SEC document
March 29, 2021 Filed Mar 30, 2021 23:21 UTC Xylem Inc. XYL · Entity 430 Exercise / conversionCommon Stock 5,897 $63.55 $374,754.35
Disclosure

SEC source: 0001209191-21-023626 · doc4.xml · nonDerivative · entry 1

Yarkadas Hayati · CIK 0001657363 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,503

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The exercise and sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 25, 2021.

Read SEC document
March 01, 2021 Filed Mar 2, 2021 21:55 UTC Xylem Inc. XYL · Entity 430 GrantStock Option (Right to Buy) · Derivative 9,698 $0.00 Strike: $102.23 $0.00
Disclosure

SEC source: 0001209191-21-016150 · doc4.xml · derivative · entry 3

Yarkadas Hayati · CIK 0001657363 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,698

Underlying: Common · 9,698 shares

Expires 2031-03-01

F4 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2022, March 1, 2023 and March 1, 2024

Read SEC document
March 01, 2021 Filed Mar 2, 2021 21:55 UTC Xylem Inc. XYL · Entity 430 GrantCommon Stock 2,201 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-016150 · doc4.xml · nonDerivative · entry 2

Yarkadas Hayati · CIK 0001657363 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,606

F3 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2022, March 1, 2023 and March 1, 2024

Read SEC document
February 27, 2021 Filed Mar 2, 2021 21:55 UTC Xylem Inc. XYL · Entity 430 SaleCommon Stock 70 $101.80 $7,125.84
Disclosure

SEC source: 0001209191-21-016150 · doc4.xml · nonDerivative · entry 1

Yarkadas Hayati · CIK 0001657363 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,405

F1 · shares: Reflects the sale of common stock to pay the tax liability incident to the vesting of restricted stock units granted on Feb 27, 2020 under the Xylem 2011 Omnibus Incentive Plan

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 70 shares that were executed at price of $101.7977. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

Read SEC document
May 07, 2020 Filed May 11, 2020 19:20 UTC Xylem Inc. XYL · Entity 430 GrantEmployee Stock Option (Right to Buy) · Derivative 17,871 $0.00 Strike: $63.55 $0.00
Disclosure

SEC source: 0001209191-20-028229 · doc4.xml · derivative · entry 3

Yarkadas Hayati · CIK 0001657363 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,871

Underlying: Common · 17,871 shares

Expires 2030-02-27

F3 · derivative.exercise_date: Reflects the grant of a non-qualified stock option which will vest in 1/3rd increments on the anniversary of the Feb 27, 2020 award date: Feb 27, 2021, Feb 27, 2022 and Feb 27, 2023

Read SEC document
May 07, 2020 Filed May 11, 2020 19:20 UTC Xylem Inc. XYL · Entity 430 GrantCommon Stock 3,934 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-028229 · doc4.xml · nonDerivative · entry 2

Yarkadas Hayati · CIK 0001657363 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,475

F2 · shares: Reflects the award of an RSU which vests in 1/3rd increments on the anniversary of the May 7, 2020 award date: May, 7, 2021, May 7, 2022 and May 7, 2023

Read SEC document
May 07, 2020 Filed May 11, 2020 19:20 UTC Xylem Inc. XYL · Entity 430 GrantCommon Stock 3,541 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-028229 · doc4.xml · nonDerivative · entry 1

Yarkadas Hayati · CIK 0001657363 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,541

F1 · shares: Reflects the grant of an RSU Award which is scheduled to vest in 1/3rd increments on the anniversary of the Feb 27, 2020 award date: Feb 27, 2021, Feb 27, 2022 and Feb 27, 2023

Read SEC document
February 26, 2019 Filed Mar 1, 2019 01:58 UTC Trinseo PLC TSE · Entity 8671 GrantOption to Purchase Ordinary Shares · Derivative 12,702 $0.00 Strike: $51.02 $0.00
Disclosure

SEC source: 0001179110-19-002837 · edgar.xml · derivative · entry 2

Yarkadas Hayati · CIK 0001657363 · SVP & Business President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,524

Underlying: Ordinary Shares · 12,702 shares

Expires 2028-02-26

F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 26, 2019 Filed Mar 1, 2019 01:58 UTC Trinseo PLC TSE · Entity 8671 GrantOrdinary Shares 3,836 $0.00 $0.00
Disclosure

SEC source: 0001179110-19-002837 · edgar.xml · nonDerivative · entry 1

Yarkadas Hayati · CIK 0001657363 · SVP & Business President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,589

F1 · shares: Represents ordinary shares issuable pursuant to RSU award that will vest in full on the third anniversary of the grant date.

Read SEC document
February 22, 2019 Filed Feb 27, 2019 02:02 UTC Trinseo PLC TSE · Entity 8671 Tax withholdingOrdinary Shares 2,376 $51.92 $123,361.92
Disclosure

SEC source: 0001179110-19-002673 · edgar.xml · nonDerivative · entry 1

Yarkadas Hayati · CIK 0001657363 · SVP & Business President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,753

F1 · shares: Shares withheld by the Company to pay taxes due following the vesting of previously granted restricted stock units.

Read SEC document
September 14, 2018 Filed Sep 18, 2018 22:09 UTC Trinseo PLC TSE · Entity 8671 GrantOrdinary Shares 8,672 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-011522 · edgar.xml · nonDerivative · entry 1

Yarkadas Hayati · CIK 0001657363 · SVP & Business President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,129

F1 · shares: Represents ordinary shares issuable pursuant to a restricted stock unit award that will vest in full on the third anniversary of the grant date.

Read SEC document
February 22, 2018 Filed Feb 26, 2018 23:17 UTC Trinseo PLC TSE · Entity 8671 GrantOption to Purchase Ordinary Shares · Derivative 9,341 $0.00 Strike: $81.20 $0.00
Disclosure

SEC source: 0001179110-18-002909 · edgar.xml · derivative · entry 2

Yarkadas Hayati · CIK 0001657363 · SVP & Business President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,822

Underlying: Ordinary Shares · 9,341 shares

Expires 2027-02-22

F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 22, 2018 Filed Feb 26, 2018 23:17 UTC Trinseo PLC TSE · Entity 8671 GrantOrdinary Shares 2,569 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-002909 · edgar.xml · nonDerivative · entry 1

Yarkadas Hayati · CIK 0001657363 · SVP & Business President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,457

F1 · shares: Represents ordinary shares issuable pursuant to a restricted stock unit award that will vest in full on the third anniversary of the grant date.

Read SEC document
February 16, 2017 Filed Feb 21, 2017 22:48 UTC Trinseo PLC TSE · Entity 8671 GrantOption to Purchase Ordinary Shares · Derivative 7,951 $0.00 Strike: $71.45 $0.00
Disclosure

SEC source: 0001179110-17-002800 · edgar.xml · derivative · entry 2

Yarkadas Hayati · CIK 0001657363 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,481

Underlying: Ordinary Shares · 7,951 shares

Expires 2026-02-16

F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 16, 2017 Filed Feb 21, 2017 22:48 UTC Trinseo PLC TSE · Entity 8671 GrantOrdinary Shares 2,294 $0.00 $0.00
Disclosure

SEC source: 0001179110-17-002800 · edgar.xml · nonDerivative · entry 1

Yarkadas Hayati · CIK 0001657363 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,888

F1 · shares: Represents ordinary shares issuable pursuant to a restricted stock unit award that will vest in full on the third anniversary of the grant date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.